This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scanga, C. A.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scanga, C. A.
Right arrow Articles by Sher, A.

 Previous Article  |  Next Article 

Infection and Immunity, April 2004, p. 2400-2404, Vol. 72, No. 4
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.4.2400-2404.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression

Charles A. Scanga,1* Andre Bafica,1 Carl G. Feng,1 Allen W. Cheever,2 Sara Hieny,1 and Alan Sher1

Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892,1 Biomedical Research Institute, Rockville, Maryland 208522

Received 22 December 2003/ Accepted 13 January 2004


arrow
ABSTRACT
 
Mycobacterium tuberculosis possesses agonists for several Toll-like receptors (TLRs), yet mice with single TLR deletions are resistant to acute tuberculosis. MyD88-/- mice were used to examine whether TLRs play any role in protection against aerogenic M. tuberculosis H37Rv infection. MyD88-/- mice failed to control mycobacterial replication and rapidly succumbed. Moreover, expressions of interleukin 12, tumor necrosis factor alpha, gamma interferon, and nitric oxide synthase 2 were markedly decreased in the knockout animals. These results argue that resistance to M. tuberculosis must depend on MyD88-dependent signals mediated by an as-yet-undetermined TLR or a combination of TLRs.


arrow
TEXT
 
Studies of both experimental models and patients with genetic defects have indicated a major role for gamma interferon (IFN-{gamma}) in host resistance to Mycobacterium tuberculosis (5, 7, 11). This typically T-lymphocyte-dependent response is thought to be driven primarily by proinflammatory cytokines such as interleukin 12 (IL-12) and IL-18 that are stimulated by innate recognition events occurring soon after initial infection. While antigen-presenting cells (APC) such as dendritic cells and macrophages are likely sources of these initiating cytokines, the receptor-mycobacterial ligand interactions responsible for APC triggering in vivo have not been clearly defined. Members of the Toll-like receptor (TLR) family are major candidates for the host receptors involved in the innate recognition of mycobacteria. TLRs are evolutionarily conserved proteins that have been shown to detect molecular patterns in nearly every class of infectious microorganism (15). Their ligation leads to proinflammatory cytokine production and up-regulated costimulatory molecule expression by APC (15). In vitro studies have shown that M. tuberculosis possesses potent agonists for a number of TLRs, including TLR2 (4, 12, 17, 28, 29) and TLR4 (1, 17). Surprisingly, mice deficient in TLR2 (18, 25), TLR4 (1, 6, 18, 23), or TLR6 (25) show no defects in acute resistance to aerogenic M. tuberculosis infections. Additionally, a recent report has shown that gene expression in macrophages infected with M. tuberculosis in vitro is largely independent of the TLR intracellular adaptor molecule myeloid differentiation factor 88 (MyD88) (22). These studies raise the question of whether TLR signaling plays any role in resistance to M. tuberculosis.

All TLRs that have so far been identified have at least one signaling pathway dependent on MyD88 (15), and thus mice deficient in MyD88 offer a system to test the hypothesis that TLR signaling is required for resistance to acute tuberculosis. Since MyD88 is also required for IL-1 receptor (IL-1R) and IL-18R signaling, the possible involvement of these receptors must also be taken into account. MyD88-/- mice have been shown to be highly susceptible to a number of pathogens, including Listeria monocytogenes (8, 21), Staphylococcus aureus (27), and Toxoplasma gondii (19), and in a recent study, we demonstrated that these animals are more susceptible to Mycobacterium avium infection than either TLR2- or TLR4-deficient mice (9).

To test the requirement for MyD88 in host resistance to aerosol M. tuberculosis infection, we infected MyD88-/- mice (3) partially backcrossed on a C57BL/6 background with 20 to 50 CFU of the virulent H37Rv strain of M. tuberculosis by using a nose-only exposure chamber (CH Technologies, Westwood, N.J.) and compared their survival and immune responses to those of wild-type control (WT) mice (Taconic Farms, Germantown, N.Y.). In three separate experiments, MyD88-deficient mice succumbed to M. tuberculosis infection within only 42 days of infection, while WT mice survived for >180 days (Fig. 1A). This mortality was indistinguishable from that observed with similarly infected IFN-{gamma}-/- mice in a separate experiment (mean survival time, 41 ± 1 days). Lungs of infected animals were removed, homogenized in phosphate-buffered saline with 0.5% Tween 80, and plated on 7H11 agar plates to enumerate the numbers of bacilli. The mycobacterial burden in the lungs of MyD88-/- mice was consistently higher than that in the WT animals at each time point examined, reaching a >3-log difference at their time of death (Fig. 1B). This increase in bacterial numbers was also evident in acid-fast stained sections of the same tissue (Fig. 2A and B). Histopathological examination at 3 weeks revealed exacerbated granulomatous inflammation and necrosis in the lungs of MyD88-/- mice relative to those of comparably infected WT animals (Fig. 2C and D), and this difference became even more pronounced at 5 weeks postinfection (data not shown). Livers from MyD88-/- mice also showed higher mycobacterial loads, particularly at 3 weeks postinfection, a time when bacterial CFU were still below the limit of detection in the WT animals (Fig. 1C). In liver tissue, sections from MyD88-/- mice showed fewer lesions (0.03 ± 0.02 granulomas/12x field) compared to those of WT animals (0.33 ± 0.18 granulomas/12x field) at the same 3 week time point (Fig. 2, compare panels E and F), despite the marked elevation in bacterial load (Fig. 1C). However, by 5 weeks, both granuloma numbers and morphology appeared comparable in the WT and MyD88-/- animals (data not shown). These findings suggest that MyD88-/- mice display both delayed initial granuloma formation as well as impaired control of bacterial growth within the mature lesions that eventually develop.



View larger version (10K):
[in this window]
[in a new window]
  		FIG. 1. MyD88-/- mice are more susceptible than WT mice to aerogenic M. tuberculosis infection. (A) MyD88-/- mice (diamonds) and C57BL/6 x 129sv (F1) WT animals (squares), used to control for the possible influence of contaminating 129 genes, were infected in groups of 5 to 7 mice with 20 to 50 CFU of M. tuberculosis and monitored for survival. Data are representative of two separate experiments. Bacterial burdens (means ± standard errors) in the lungs (B) or livers (C) were also measured in three mice per group at the times indicated. Asterisks indicate statistically significant (P <= 0.05) differences determined by unpaired t test after log transformation between CFU values in MyD88-/- and WT animals. Data are representative of the results from two experiments.



View larger version (104K):
[in this window]
[in a new window]
  		FIG. 2. MyD88-/- mice infected with M. tuberculosis exhibit more bacilli, exacerbated pathology, and reduced NOS2 expression in lungs, as well as delayed granuloma formation in liver. Formalin-fixed, paraffin-embedded lung (A to D, G, and H) and liver (E and F) tissue sections from mice 3 weeks after infection with aerosol M. tuberculosis were stained by the Kinyoun acid-fast method to detect mycobacteria (red staining) (A and B) or with hematoxylin and eosin stain (C to F). Note the absence of granulomas in panel F. NOS2 was visualized immunohistochemically in serial sections of these same tissues (G and H). Sections shown are representative of multiple fields from the organs of at least three animals per group. Original magnifications are x63 (A and B), x5 (C and D), x10 (E and F), and x20 (G and H).

We next investigated the immunologic defect(s) responsible for the striking susceptibility to M. tuberculosis exhibited by MyD88-/- animals. Total RNA was isolated from the lungs by using Trizol (Invitrogen, San Diego, Calif.), and cDNA was prepared by using Superscript reverse transcriptase (RT; Invitrogen) and subjected to quantitative real-time RT-PCR analysis with previously described primers (9) and a 7900HT sequence detection system (Applied Biosystems, Foster City, Calif.). IL-12 and IFN-{gamma}, two cytokines required for control of M. tuberculosis in mice (10) and implicated in mycobacterial resistance in humans (5), are induced by a number of pathogens in an MyD88-dependent manner (2, 9, 19, 21). We observed significantly less IL-12p40 and IFN-{gamma} mRNA in the lungs of M. tuberculosis-infected MyD88-/- mice than in similarly infected WT mice at both 2 and 3 weeks postinfection (Fig. 3A and B). Transcripts for tumor necrosis factor alpha (TNF-{alpha}), another proinflammatory cytokine required for resistance to M. tuberculosis infection (10), were also reduced significantly in the lungs of infected MyD88-deficient animals (Fig. 3C).



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 3. Expression of IL-12, IFN-{gamma}, and TNF-{alpha}, as well as NOS2, is impaired in MyD88-/- mice following aerogenic M. tuberculosis infection. Real-time RT-PCR was used to quantitate IL-12p40 (A), IFN-{gamma} (B), TNF-{alpha} (C), and NOS2 (F) mRNA expression in the lungs of infected WT (gray bars) and MyD88-/- (black bars) mice. In parallel experiments, splenocytes from infected WT and MyD88-/- mice were isolated and restimulated with purified protein derivative, and the supernatants were analyzed 3 days later for IL-12p40 (D) and IFN-{gamma} (E) by enzyme-linked immunosorbent assay. Each bar is the mean (± standard deviation) of data from three mice. Asterisks indicate a P value of <=0.05 determined by unpaired t test. Data are representative of results from three experiments.

The defects in the IL-12 and IFN-{gamma} responses in the knockout (KO) animals as detected by real-time RT-PCR in vivo were investigated further in ex vivo restimulation experiments. Splenocytes were plated at 5 x 105 cells/well in 96-well plates and restimulated with purified protein derivative (Statens Seruminstitut, Copenhagen, Denmark), and IL-12p40 and IFN-{gamma} were quantitated in supernatants 3 days later by enzyme-linked immunosorbent assay as described previously (19). At 2 and 4 weeks postinfection, splenocytes from M. tuberculosis-infected MyD88-/- mice made significantly less IL-12p40 and IFN-{gamma} than did spleen cells from infected WT animals (Fig. 3D and E). Nevertheless, it is important to note that for each of the cytokines studied in vivo and ex vivo, a significant level of cytokine expression was evident even in the MyD88-/- animals, suggesting the existence of alternative signaling pathways for generating these responses.

IFN-{gamma} plays a major role in the up-regulation of nitric oxide synthase 2 (NOS2) and the subsequent production of NO, a metabolite with antimycobacterial activity both in vivo and in vitro (10). We assessed whether impaired NO synthesis might contribute to the enhanced susceptibility of MyD88-/- mice to M. tuberculosis by measuring NOS2 gene expression as well as its production in situ in the lungs of infected mice. MyD88-/- mice showed markedly reduced NOS2 mRNA levels compared to those of WT animals by 3 weeks postinfection (Fig. 3F). Moreover, immunohistochemical staining for NOS2, performed as described previously (20), was greatly diminished in the lungs of the KO mice compared to those of WT animals at the same time point (Fig. 2G and H). Therefore, M. tuberculosis-induced NOS2 expression in vivo is largely dependent on MyD88, a finding which contrasts with the conclusion of in vitro studies in which the induction of NOS2 expression by M. tuberculosis was observed to be MyD88-independent (16, 22). This discrepancy may reflect additional downstream effects of MyD88 deficiency on NOS2 gene induction by M. tuberculosis in vivo versus in vitro.

These findings establish that host resistance to infection with M. tuberculosis H37Rv is dependent on MyD88 and therefore strongly implicate TLR and/or IL-1/IL-18 receptor signaling in this response. Previous studies using mice deficient in IL-1 (30), IL-1R (13), or IL-18 (14, 24) have revealed minor roles for these signaling elements in the control of M. tuberculosis relative to the role described here for MyD88. Therefore, our results argue for a major function of TLRs in host defense against this pathogen and are consistent with previous data demonstrating a requirement for MyD88 in resistance to M. avium infection (9).

Our findings are, however, in partial disagreement with a recently published study in which MyD88-/- mice aerogenically infected with the Kurono strain of M. tuberculosis showed no increase in mortality, despite developing higher bacterial loads than WT animals (26). Moreover, no significant reduction in proinflammatory or Th1 cytokine production was observed in the infected MyD88-/- animals (26). Since a similar infection protocol was used in both this and the present study, it is likely that the disparate results relate to differences in the bacterial strains employed. An alternative possibility is that the discrepancy is due to differences in the genetic background of the KO mice used in the two studies.

While MyD88 appears to regulate resistance to at least some M. tuberculosis strains, the specific TLRs involved have yet to be defined. Previous studies investigating TLR2 (18, 25), TLR4 (1, 6, 18, 23), or TLR6 (25) have revealed only a minor influence of these TLRs in the early control of M. tuberculosis. Therefore, either a TLR not yet tested or a combination of different TLRs is likely to explain the MyD88 dependency of host resistance to M. tuberculosis. Since M. tuberculosis H37Rv-infected MyD88-/- mice showed impaired IL-12, IFN-{gamma}, TNF-{alpha}, and NOS2 responses, it is reasonable to speculate that the TLR signaling pathways involved determine host control of infection by regulating the production of these four mediators, known to be required for resistance to M. tuberculosis in mice (10). However, since MyD88 deficiency did not result in a complete elimination of IL-12, IFN-{gamma}, TNF-{alpha}, or NOS2 expression, it is possible that other as-yet-unidentified, TLR-dependent immune responses contribute to control of this important pathogen.


arrow
ACKNOWLEDGMENTS
 
We thank Shizuo Akira and Douglas Golenbach for generously providing the original MyD88-/- breeders. We are also grateful to Sandy White and Jacqueline Gonzales for technical assistance and Dragana Jankovic for critical reading of this paper.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Building 50, Room 6148, 50 South Dr., Bethesda, MD 20892-8003. Phone: (301) 594-3454. Fax: (301) 402-0890. E-mail: cscanga{at}niaid.nih.gov. Back

Editor: J. F. Urban, Jr.


arrow
REFERENCES
 
    1
  1. Abel, B., N. Thieblemont, V. J. F. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155-3162.[Abstract/Free Full Text]
    2. 2
  2. Adachi, K., H. Tsutsui, S.-I. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, S. Akira, and K. Nakanishi. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12 and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167:5928-5934.[Abstract/Free Full Text]
    3. 3
  3. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.[CrossRef][Medline]
    4. 4
  4. Brightbill, H. D., D. H. Libratey, S. R. Krutzik, R. B. Yang, J. T. Belisle, S. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736.[Abstract/Free Full Text]
    5. 5
  5. Casanova, J. L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620.[CrossRef][Medline]
    6. 6
  6. Chackerian, A. A., T. V. Perera, and S. M. Behar. 2001. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69:2666-2674.[Abstract/Free Full Text]
    7. 7
  7. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffen, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in IFN-{gamma} gene-disrupted mice. J. Exp. Med. 178:2243-2248.[Abstract/Free Full Text]
    8. 8
  8. Edelson, B. T., and E. R. Unanue. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-3875.[Abstract/Free Full Text]
    9. 9
  9. Feng, C. G., C. A. Scanga, C. M. Collazo-Custodio, A. W. Cheever, S. Hieny, P. Caspar, and A. Sher. 2003. Mice lacking myeloid differentiation factor 88 display profound effects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J. Immunol. 171:4758-4764.[Abstract/Free Full Text]
    10. 10
  10. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.[CrossRef][Medline]
    11. 11
  11. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. Stewart, and B. R. Bloom. 1993. An essential role for interferon-{gamma} in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.[Abstract/Free Full Text]
    12. 12
  12. Jones, B. W., T. K. Means, K. A. Heldwein, M. A. Keen, P. J. Hill, J. T. Belisle, and M. J. Fenton. 2001. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 69:1036-1044.[Abstract/Free Full Text]
    13. 13
  13. Juffermans, N. P., S. Florquin, L. Camoglio, A. Verbon, A. H. Kolk, P. Speelman, S. J. H. van Deventer, and T. van der Poll. 2000. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182:902-908.[CrossRef][Medline]
    14. 14
  14. Kinjo, Y., K. Kawakami, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Hoshino, M. Okamoto, Y. Kawase, K. Yokota, K. Yoshino, K. Takeda, S. Akira, and A. Saito. 2002. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol. 169:323-329.[Abstract/Free Full Text]
    15. 15
  15. Kopp, E., and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396-401.[CrossRef][Medline]
    16. 16
  16. Means, T. K., B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, and M. J. Fenton. 2001. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:4074-4082.[Abstract/Free Full Text]
    17. 17
  17. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by M. tuberculosis. J. Immunol. 163:3920-3927.[Abstract/Free Full Text]
    18. 18
  18. Reiling, N., C. Holscher, A. Fehrenbach, S. Kroger, C. J. Kirschning, S. Goyert, and S. Ehlers. 2002. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:3480-3484.[Abstract/Free Full Text]
    19. 19
  19. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997-6001.[Abstract/Free Full Text]
    20. 20
  20. Scanga, C. A., V. P. Mohan, K. Yu, H. Joseph, K. Tanaka, J. Chan, and J. L. Flynn. 2000. Depletion of CD4+ T cells causes reactivation of murine latent tuberculosis despite continued expression of IFN-{gamma} and NOS2. J. Exp. Med. 192:347-358.[Abstract/Free Full Text]
    21. 21
  21. Seki, E., H. Tsutsui, N. M. Tsuji, N. Hayashi, K. Adachi, H. Nakano, S. Futatsugi-Yumikura, O. Takeuchi, K. Hoshino, S. Akira, J. Fujimoto, and K. Nakanishi. 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes. J. Immunol. 169:3863-3868.[Abstract/Free Full Text]
    22. 22
  22. Shi, S., C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gringeras, G. Schoolnik, S. Akira, K. Takeda, and S. Ehrt. 2003. MyD88 primes macrophages for full-scale activation by interferon-{gamma} yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198:987-997.[Abstract/Free Full Text]
    23. 23
  23. Shim, T. S., O. C. Turner, and I. M. Orme. 2003. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 83:367-371.[CrossRef]
    24. 24
  24. Sugawara, I., H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira. 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:2585-2589.[Abstract/Free Full Text]
    25. 25
  25. Sugawara, I., H. Yamada, C. Li, S. Mizuno, O. Takeuchi, and S. Akira. 2003. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47:327-336.[Medline]
    26. 26
  26. Sugawara, I., H. Yamada, S. Mizuno, K. Takeda, and S. Akira. 2003. Mycobacterial infection in MyD88-deficient mice. Microbiol. Immunol. 47:841-847.[Medline]
    27. 27
  27. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.[Abstract/Free Full Text]
    28. 28
  28. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, S. Akira, M. V. Norgard, J. T. Belisle, P. J. Godowski, B. R. Bloom, and R. L. Modlin. 1999. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544-1547.
    29. 29
  29. Underhill, D. M., A. Ozinsky, K. D. Smith, and A. Aderem. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459-14465.[Abstract/Free Full Text]
    30. 30
  30. Yamada, H., S. Mizuno, R. Horai, Y. Iwakura, and I. Sugawara. 2000. Protective role of interleukin-1 in mycobacterial infection in IL-1{alpha}/ß double-knockout mice. Lab. Investig. 80:759-767.[Medline]

Infection and Immunity, April 2004, p. 2400-2404, Vol. 72, No. 4
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.4.2400-2404.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zhao, Y., De Trez, C., Flynn, R., Ware, C. F., Croft, M., Salek-Ardakani, S. (2009). The Adaptor Molecule MyD88 Directly Promotes CD8 T Cell Responses to Vaccinia Virus. J. Immunol. 182: 6278-6286 [Abstract] [Full Text]  
  • Divangahi, M., Mostowy, S., Coulombe, F., Kozak, R., Guillot, L., Veyrier, F., Kobayashi, K. S., Flavell, R. A., Gros, P., Behr, M. A. (2008). NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity. J. Immunol. 181: 7157-7165 [Abstract] [Full Text]  
  • Rahman, A. H., Cui, W., LaRosa, D. F., Taylor, D. K., Zhang, J., Goldstein, D. R., Wherry, E. J., Kaech, S. M., Turka, L. A. (2008). MyD88 Plays a Critical T Cell-Intrinsic Role in Supporting CD8 T Cell Expansion during Acute Lymphocytic Choriomeningitis Virus Infection. J. Immunol. 181: 3804-3810 [Abstract] [Full Text]  
  • De Pascalis, R., Taylor, B. C., Elkins, K. L. (2008). Diverse Myeloid and Lymphoid Cell Subpopulations Produce Gamma Interferon during Early Innate Immune Responses to Francisella tularensis Live Vaccine Strain. Infect. Immun. 76: 4311-4321 [Abstract] [Full Text]  
  • Sukhumavasi, W., Egan, C. E., Warren, A. L., Taylor, G. A., Fox, B. A., Bzik, D. J., Denkers, E. Y. (2008). TLR Adaptor MyD88 Is Essential for Pathogen Control during Oral Toxoplasma gondii Infection but Not Adaptive Immunity Induced by a Vaccine Strain of the Parasite. J. Immunol. 181: 3464-3473 [Abstract] [Full Text]  
  • Semnani, R. T., Venugopal, P. G., Leifer, C. A., Mostbock, S., Sabzevari, H., Nutman, T. B. (2008). Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood 112: 1290-1298 [Abstract] [Full Text]  
  • Rodriguez, N., Mages, J., Dietrich, H., Wantia, N., Wagner, H., Lang, R., Miethke, T. (2007). MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol. Genomics 30: 134-145 [Abstract] [Full Text]  
  • Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., Quesniaux, V. F. J. (2007). IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. J. Immunol. 179: 1178-1189 [Abstract] [Full Text]  
  • Liu, C.-H., Machado, F. S., Guo, R., Nichols, K. E., Burks, A. W., Aliberti, J. C., Zhong, X.-P. (2007). Diacylglycerol kinase {zeta} regulates microbial recognition and host resistance to Toxoplasma gondii. JEM 204: 781-792 [Abstract] [Full Text]  
  • Pompei, L., Jang, S., Zamlynny, B., Ravikumar, S., McBride, A., Hickman, S. P., Salgame, P. (2007). Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs. J. Immunol. 178: 5192-5199 [Abstract] [Full Text]  
  • Teixeira, F. M., Teixeira, H. C., Ferreira, A. P., Rodrigues, M. F., Azevedo, V., Macedo, G. C., Oliveira, S. C. (2006). DNA Vaccine Using Mycobacterium bovis Ag85B Antigen Induces Partial Protection against Experimental Infection in BALB/c Mice.. CVI 13: 930-935 [Abstract] [Full Text]  
  • Pecora, N. D., Gehring, A. J., Canaday, D. H., Boom, W. H., Harding, C. V. (2006). Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function. J. Immunol. 177: 422-429 [Abstract] [Full Text]  
  • van der Sar, A. M., Stockhammer, O. W., van der Laan, C., Spaink, H. P., Bitter, W., Meijer, A. H. (2006). MyD88 Innate Immune Function in a Zebrafish Embryo Infection Model. Infect. Immun. 74: 2436-2441 [Abstract] [Full Text]  
  • Teng, Y.-T.A. (2006). Protective and Destructive Immunity in the Periodontium: Part 1--Innate and Humoral Immunity and the Periodontium. JDR 85: 198-208 [Abstract] [Full Text]  
  • Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., Sher, A. (2005). TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. JEM 202: 1715-1724 [Abstract] [Full Text]  
  • Su, S. B., Silver, P. B., Grajewski, R. S., Agarwal, R. K., Tang, J., Chan, C.-C., Caspi, R. R. (2005). Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity. J. Immunol. 175: 6303-6310 [Abstract] [Full Text]  
  • Shi, S., Blumenthal, A., Hickey, C. M., Gandotra, S., Levy, D., Ehrt, S. (2005). Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-{alpha}{beta} Receptor and STAT1. J. Immunol. 175: 3318-3328 [Abstract] [Full Text]  
  • Matsumoto, S., Matsumoto, M., Umemori, K., Ozeki, Y., Furugen, M., Tatsuo, T., Hirayama, Y., Yamamoto, S., Yamada, T., Kobayashi, K. (2005). DNA Augments Antigenicity of Mycobacterial DNA-Binding Protein 1 and Confers Protection against Mycobacterium tuberculosis Infection in Mice. J. Immunol. 175: 441-449 [Abstract] [Full Text]  
  • Yang, R., Murillo, F. M., Delannoy, M. J., Blosser, R. L., Yutzy, W. H. IV, Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., Roden, R. B. S. (2005). B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88. J. Immunol. 174: 7912-7919 [Abstract] [Full Text]  
  • Bulut, Y., Michelsen, K. S., Hayrapetian, L., Naiki, Y., Spallek, R., Singh, M., Arditi, M. (2005). Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals. J. Biol. Chem. 280: 20961-20967 [Abstract] [Full Text]  
  • Bafica, A., Scanga, C. A., Schito, M., Chaussabel, D., Sher, A. (2004). Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors. J. Immunol. 172: 7229-7234 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scanga, C. A.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scanga, C. A.
Right arrow Articles by Sher, A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»